Sprout Health vs bmiMD: Fast Start or Lower Long-Term Cost?
If you need a fast, low-friction start Sprout Health emphasizes lightning-quick approval and a $50 first-month offer; bmiMD focuses on tirzepatide subscription pricing with lower long-term monthly equivalents and free shipping. Early verdict: Choose Sprout Health for fastest entry; choose bmiMD for lower long-term monthly cost when you commit to longer plans.
Start Sprout Health with $50 Off
Sprout Health vs bmiMD: what differs most
This comparison uses only captured provider facts. The most distinctive differences are: pricing structure and initial discount, medication type and active ingredient, approval speed and onboarding friction, long-term cost commitments and billing options, and shipping and clinician access. Each difference below compares Sprout Health and bmiMD directly.
1) Pricing structure and initial cost
Sprout Health highlights a $50 off first month offer, bringing the initial month to $199, with ongoing pricing at $249/month after the discount. bmiMD lists multiple billing options for compounded tirzepatide: $179 month-to-month, $159 per month on a three-month plan, $149 per month on a six-month plan, and $139 per month on a 12-month plan. The clear contrast is one-time introductory discount versus multi-month pricing tiers that lower the monthly equivalent with longer commitments.
2) Medication type and advertised outcomes
Sprout Health markets compounded semaglutide with a framing of 10–26% body weight loss over 12 months and notes the compounded medication is not FDA-approved. bmiMD offers compounded tirzepatide, also noting compounded medications are not FDA-approved. Sprout Health emphasizes an outcome range in marketing; bmiMD emphasizes tirzepatide as its active compounded GLP-1/GIP option.
3) Approval speed, onboarding friction, and clinician access
Sprout Health positions itself as lightning-quick approval with a fully online, fast-entry experience and minimal onboarding friction. bmiMD offers clinician-reviewed online treatment and 24/7 clinician access, with online refills and delivery. If immediate approval speed is the priority, Sprout Health emphasizes that advantage. If ongoing clinician access after start is a priority, bmiMD documents 24/7 clinician access.
4) Shipping, commitments, and long-term cost
bmiMD highlights free subscription shipping and lower long-term monthly equivalents at longer commitments, but notes the lowest price requires a 12-month commitment and that total prepaid charge should be confirmed. Sprout Health captured shipping, fees, membership, and cancellation details were not verified on the captured page. Both providers state their compounded medications are not FDA-approved.
| Criteria | Sprout Health | bmiMD |
|---|---|---|
| Starting price or offer | $50 off first month, initial month $199; $249/month ongoing | Tirzepatide plans: $179/mo 1 month; $159/mo 3 mo; $149/mo 6 mo; $139/mo 12 mo |
| Medication type | Compounded semaglutide; compounded meds not FDA-approved | Compounded tirzepatide (GLP-1/GIP); compounded meds not FDA-approved |
| Approval and onboarding | Lightning-quick approval; fully online fast-entry experience | Clinician-reviewed online treatment with 24/7 clinician access |
| Shipping and refills | Shipping/fees not verified on captured page | Free subscription shipping; online refills and delivery |
| Best for | Patients who want fast, low-friction entry to GLP-1 therapy | People who confirm eligibility, total cost, renewal terms and state availability before enrollment |
Comparing the trade offs
Sprout Health trades a larger ongoing monthly price for a fast start and a visible first-month discount and outcome framing. bmiMD trades the fastest single-month start price for multi-month commitments that lower the monthly equivalent and add free shipping and clinician access. Both use compounded medications and both state treatment is available only when a licensed clinician determines it is medically appropriate.
Regulatory and eligibility notes
Both providers explicitly state compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Both note that treatment is available only when a licensed clinician determines it is medically appropriate. bmiMD adds that compounded medication batches are prepared in a state-licensed pharmacy and independently verified in labs per its captured page.
Confirm bmiMD eligibility and shipping
Conclusion: Sprout Health vs bmiMD
Sprout Health vs bmiMD comes down to speed versus long-term plan pricing. Sprout Health stands out for lightning-quick approval and a $50 first-month discount, framed around 10–26% weight loss over 12 months. bmiMD stands out for tirzepatide subscription tiers, free shipping, 24/7 clinician access, and a lower monthly equivalent with longer commitments. Both use compounded medications and both require clinician approval.
Choose Sprout Health if you want the fastest, lowest-friction entry and a one-time $50 introductory discount. Choose bmiMD if you prefer tirzepatide, free subscription shipping, 24/7 clinician access and lower long-term monthly cost with a multi-month plan commitment.
Choose Sprout Health if you prioritize speed and a clear introductory price. Choose bmiMD if you prioritize lower monthly equivalents with longer commitments, free shipping, and ongoing clinician access.